Industries de la santé
29 Mai 2017
The hematological cancers pipeline, which covers leukemia, lymphoma and myeloma, is the largest within the oncology therapy area of pharmaceuticals, with 1,474 programs in active development and a total of 477 first-in-class pipeline programs, according to business intelligence provider GBI Research. |The company’s latest report states that cytokine signaling targets make up the greatest...
Plus d'articles...
- Merck announces 2016 winners and calls for applications for the 2017 Hypertension Award to mark “World Hypertension Day”
- VALBIOTIS LANCE SON INTRODUCTION EN BOURSE SUR LE MARCHE ALTERNEXT PARIS
- Merck’s CHOZN® Expression System Selected for Bi-specific Antibody Development by SystImmune
- Ascom Digistat® renforce l'efficacité des flux de travail hospitaliers grâce à une intégration complète et partagée des dispositifs médicaux